What Is the COVID Cycle Threshold and Why Does It Matter?

The cycle threshold, usually written as Ct, is the number of amplification rounds a PCR test needs before it picks up enough viral genetic material to register as positive. A low Ct means the machine found abundant virus quickly; a high Ct means it had to work harder, amplifying through many more rounds before detecting anything. That single number turns out to carry a surprising amount of information about how sick someone might get, how contagious they are, and even how an outbreak is unfolding at the population level.

How the Number Is Generated

When you get a COVID PCR test, a nasal or throat swab is sent to a lab where technicians run a process called reverse transcription quantitative polymerase chain reaction (RT-qPCR). The test converts any SARS-CoV-2 RNA in the sample into DNA, then doubles that DNA over and over. Each doubling is one “cycle.” A fluorescent signal grows with each cycle, and the moment that signal crosses a preset brightness threshold, the machine records the cycle number. That number is the Ct value. If the virus is plentiful in your sample, the signal crosses the threshold early, perhaps at cycle 15 or 18. If there is very little virus, it might take 35 or even 40 cycles before the signal becomes visible.

A result is usually called positive if the Ct falls below a cutoff set by the test manufacturer, often around 35 to 40 depending on the assay. Anything above that cutoff is reported as negative. The key point for everything that follows is that Ct and viral load move in opposite directions: lower Ct equals more virus, higher Ct equals less virus.

Ct Values and Viral Load

Because each PCR cycle roughly doubles the amount of genetic material, the relationship between Ct and the quantity of virus in a sample is exponential. A sample with a Ct of 20 contains roughly a thousand times more viral RNA than a sample with a Ct of 30. Researchers have generally categorized Ct values below 25 as indicating high viral load, values between 25 and 30 as moderate, and values above 30 as low.¹ This rough scale is not standardized across all labs, but it gives clinicians and public health officials a useful shorthand for thinking about how much virus a person is carrying.

What Ct Tells Us About Contagiousness

One of the most practical questions about Ct is whether it predicts how infectious someone actually is. The answer, broadly, is yes. Researchers in England tested whether they could grow live virus from patient samples and found that the probability of culturing viable virus dropped sharply as Ct climbed. In samples with a Ct above 35, the chance of recovering infectious virus fell to around 8%. The probability also dropped to about 6% in samples collected more than 10 days after symptom onset, regardless of whether the patient had symptoms.²

This matters because PCR tests can stay positive for weeks after someone stops being contagious. The test detects fragments of viral RNA, not necessarily live virus. A person with a Ct of 37 on day 14 of their illness almost certainly is not spreading infection, even though the test still lights up. That distinction between “detectable RNA” and “transmissible virus” is something Ct values help clarify, at least in a general sense.

Predicting Disease Severity

Ct values measured at hospital admission have also been linked to how badly COVID hits. A study developing a mortality risk score for hospitalized patients found that a Ct value of 26 or below at admission was a significant predictor of death, alongside factors like age over 70 and low oxygen saturation.³ Separately, research from a country with endemic MERS-CoV found that patients in the lowest Ct groups had roughly double the odds of dying compared to those with higher Ct values, and the rates of invasive mechanical ventilation were also significantly elevated in the low-Ct groups.⁴

Another study looking at both Ct values and chest CT scans found that lung involvement visible on imaging was a stronger single predictor of ICU admission or death, but adding Ct values to the picture improved prediction accuracy. The Ct reading was especially useful for flagging patients who had limited visible lung damage but were still at high risk for deterioration.⁵ In other words, Ct filled in gaps that imaging alone missed.

Why You Cannot Compare Ct Values Across Labs

Here is where things get complicated. Ct values are not standardized. Different PCR test kits, different machines, and different labs can produce meaningfully different Ct numbers from the same sample. A quality assessment study that sent identical specimens to multiple laboratories using various RT-PCR kits found wide variation in the Ct values reported back, with significant differences in PCR efficiency across systems.⁶

This variability is why most health authorities have stopped short of recommending that Ct values be routinely reported to patients. The number on your lab slip depends partly on which kit and which gene target the lab happened to use, how the sample was collected and transported, and how far along the infection was when you were swabbed. A Ct of 28 from one lab does not necessarily mean the same thing as a Ct of 28 from a lab across town. Advocates for reporting Ct values argue that, even with these caveats, the information helps guide clinical decisions. The debate within the laboratory community remains unresolved.⁷

Vaccination and Its Effect on Ct Values

Early in the vaccination campaigns, one big question was whether vaccinated people who caught COVID anyway carried less virus. The evidence on this evolved as new variants appeared. A large study from Qatar found that breakthrough infections in vaccinated individuals consistently showed higher mean Ct values than primary infections in unvaccinated people. The gap was about 1.3 cycles higher for Pfizer breakthroughs, about 3.2 cycles higher for Moderna breakthroughs, and about 4.0 cycles higher for reinfections. Because Ct and infectiousness are inversely linked, the findings suggested that vaccinated individuals who got infected were somewhat less contagious.⁸

However, this picture changed once Omicron arrived. Research tracking Ct values over time during both the Delta and Omicron waves found that while a recent third vaccine dose still raised Ct somewhat during the Omicron period, the gap between vaccinated and unvaccinated individuals shrank substantially. During Delta, a recent third dose was associated with a Ct roughly 1.9 cycles above unvaccinated levels; during Omicron, that advantage was cut nearly in half. For people whose vaccination was not recent, there was essentially no difference in Ct between vaccinated and unvaccinated Omicron cases.⁹ A study focused on Omicron in Ontario similarly found that the difference between booster-dose cases and unvaccinated cases, while statistically real, was modest in absolute terms.¹⁰

So vaccines did reduce peak viral loads, but the benefit varied by variant and waned over time. More recent analyses have confirmed that the impact of vaccination on Ct values became less pronounced as the pandemic progressed and immune-evasive variants emerged.¹¹

Differences Between Variants

Not all SARS-CoV-2 variants produce the same viral loads or the same Ct profiles. A study comparing Omicron and Delta found that Omicron generated higher viral loads and prolonged viral shedding in the upper respiratory tract compared to Delta, particularly in nasopharyngeal samples.¹² In children, both the Delta and Omicron periods showed significantly lower Ct values (meaning higher viral loads) than the pre-Delta period. Interestingly, children under one year of age infected during the Delta wave had particularly low Ct values compared to older children and compared to infants infected during the Omicron wave.¹³

These variant-level differences matter because they complicate any attempt to set fixed Ct thresholds. A cutoff that worked well for the original strain or Alpha might perform differently for Delta or Omicron, and new variants continue to emerge. This is one more reason why blanket policies based on a single Ct number have been hard to implement.

Rapid Antigen Tests and the Ct Connection

If you have ever wondered why a rapid antigen test came back negative while a PCR test caught the infection, Ct values help explain the discrepancy. Rapid tests are designed to detect viral protein, not genetic material, and they need a certain amount of virus present to trigger a visible line. One study found that when PCR Ct values were 20 or below, rapid antigen tests caught every positive case. But at Ct values between 21 and 25, sensitivity dropped to around 63%, and at Ct values between 26 and 30, it fell to about 22%.¹⁴ A separate validation study in asymptomatic people reported sensitivity above 93% when Ct was under 25, plummeting to roughly 29% when Ct was above 25.¹⁵

From a practical standpoint, this means rapid tests work best during the phase of infection when viral load is highest, typically a few days around symptom onset. They are much less reliable at catching very early infections or late-stage infections when viral load is waning. A negative rapid test does not necessarily mean you are virus-free; it may mean the virus level is below the test’s detection floor.

Immunocompromised Patients and Prolonged Shedding

Most people with healthy immune systems clear SARS-CoV-2 within about 10 days, and their Ct values climb steadily during that time. But immunocompromised individuals can be a different story entirely. Patients with weakened immune systems, particularly those with B-cell dysfunction from conditions like lymphoma or from treatments such as rituximab, have been documented shedding infectious virus for weeks. In one case, a lymphoma patient on rituximab still had positive viral cultures more than 20 days after symptom onset.¹⁶

Researchers have recommended that for immunocompromised patients, isolation decisions should not rely solely on time-based rules (like the standard 5-or-10-day window) but should incorporate virological assessment, including Ct values, to judge whether the patient is still shedding transmissible virus.¹⁷ This is one of the clearest clinical use cases for Ct: it helps identify the unusual patients who remain contagious long after most people would have cleared the virus.

Children Versus Adults

Early in the pandemic, there was significant debate about whether children carried less virus than adults and therefore posed lower transmission risk. Research comparing Ct values across age groups found that children, including infants, had similar Ct values to adults when samples were collected at equivalent points in the illness. Infants tended to be sampled earlier after symptom onset, which initially made their Ct values appear different, but once that timing was accounted for, the difference disappeared.¹⁸ The practical implication: children can harbor just as much virus as adults, even if they are less likely to develop severe symptoms.

Isolation Policy and Resource Allocation

One area where Ct values had direct policy relevance was in managing hospital beds and isolation facilities during surges. Research suggested that patients with Ct values of 31 or above at diagnosis cleared the virus more quickly and could potentially be given shorter isolation periods, freeing up beds and reducing strain on healthcare infrastructure.¹⁹ Other studies echoed the idea that Ct-guided discharge protocols could help optimize limited hospital resources without meaningfully increasing transmission risk.²⁰

These proposals never became universal policy, in large part because of the lab variability issue. Without standardization across testing platforms, regulators were understandably cautious about telling hospitals to discharge patients based on a number that could mean different things depending on which machine ran the test. Still, within individual hospital systems using a single assay, Ct-guided protocols did get used during peak surges when bed space was critically short.

Tracking Outbreaks at the Population Level

Beyond individual patients, Ct values carry population-level information. Researchers demonstrated that the distribution of Ct values observed under random or symptom-based surveillance shifts predictably during an epidemic. When a wave is building, a higher share of tested individuals show low Ct values (high viral load), because more people are in the early, most infectious phase of infection. As a wave recedes, average Ct values climb. This means that even a limited number of random samples, with their Ct values, can help estimate an outbreak’s trajectory without requiring exhaustive case counts.²¹ During the second wave in some regions, a surge in the proportion of samples with Ct below 25 served as an early warning signal before case counts fully reflected the growing wave.¹

S-Gene Target Failure and Variant Surveillance

PCR tests typically target multiple genes in the SARS-CoV-2 genome. When certain variants carry deletions in the spike gene, one of those gene targets fails to amplify while the others still register. This pattern, known as S-gene target failure (SGTF), became a rapid and inexpensive way to flag the likely presence of specific variants before full genome sequencing could be completed. The approach was used extensively during the Alpha and Omicron waves. An analysis of over 2,300 sequenced samples found that SGTF identified Alpha with sensitivity and specificity above 98%, and performed similarly well for Omicron.²² In the Greater Toronto Area, SGTF tracked the spread of B.1.1.7 (Alpha) closely, with prevalence from SGTF monitoring matching independent surveys, though with an imperfect specificity of about 98% because non-target variants sometimes triggered false signals.²³

SGTF is not, strictly speaking, a Ct value application. It is a pattern in which gene targets do and do not amplify. But it is a byproduct of the same PCR infrastructure that generates Ct data, and it illustrates how the multi-target design of these tests carries more information than a simple positive or negative result. During a pandemic, squeezing every bit of signal out of routine testing was a recurring theme, and Ct-related data were central to that effort.

Wastewater Monitoring

One of the more creative uses of PCR Ct values during the pandemic involved not swabbing people at all but testing sewage. Wastewater surveillance programs used RT-qPCR to measure SARS-CoV-2 RNA concentrations in municipal sewage. The process works on the same principle: known concentrations of positive control standards are plotted against their Ct values, and the concentration of virus in an unknown wastewater sample is extrapolated from its Ct.²⁴ Because infected individuals shed viral RNA in stool regardless of whether they get tested or report symptoms, wastewater Ct trends provided an early and unbiased signal of community spread, sometimes detecting surges days before clinical case counts reflected them. Many cities and countries adopted wastewater surveillance as a complement to clinical testing, and it has continued into the post-emergency phase of the pandemic as a monitoring tool.